Barbara Ryan, Chief Executive Officer at MiNK Therapeutics, Inc. (INKT), sold 6,938 shares at $10.56 ($73K) on 2026-10-12, disclosed to the SEC on 2026-10-14.
Open-market sale of $73k INKT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.